Special Conditions of NOAC PCI
RE-DUAL PCI™ vs PIONEER AF-PCI™
ENTRUST AF PCI
Antithrombotic Therapy in AF Patients Undergoing PCI - ppt download
Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions
Objectives, The Site, Finance, and Role of The Ethics Committee, Sponsor and Research Organization
Antithrombotic Therapy in AF Patients Undergoing PCI - ppt download
ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting
Antithrombotic Therapy in AF Patients Undergoing PCI - ppt download
ENTRUST AF PCI
ENTRUST AF PCI
Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study | PLOS ONE
Can the Dual vs Triple Therapy Controversy in Patients With AF Undergoing PCI Be Put to Rest? - ppt download
ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based antithrombotic regimen following successful coronary stenting in atrial fibrillation patients
Antithrombotic Therapy in AF Patients Undergoing PCI - ppt download
Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting - Kozieł - 2020 - Research and Practice in Thrombosis and Haemostasis - Wiley Online Library
The Challenge of AF and PCI: Practical Strategies to Improve Outcomes - ppt download
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation ( ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet
Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI
ENTRUST AF PCI
Direct-acting Anticoagulants in Chronic Coronary Syndromes | ECR Journal
ENTRUST AF PCI
The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status | tctmd.com
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation ( ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet
ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting
